HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system.

AbstractBACKGROUND:
Tumors can be targeted by the adoptive transfer of chimeric antigen receptor (CAR) redirected T-cells. Antigen-specific expansion protocols are needed to generate large quantities of redirected T-cells. We aimed to establish a protocol to expand functional active NY-ESO-1-specific redirected human CD8(+) T-cells.
MATERIALS AND METHODS:
The anti-idiotypic Fab antibody A4 with specificity for HLA-A 0201/NY-ESO-1157-165 was tested by competition assays using a HLA-A 0201/NY-ESO-1157-165 tetramer. HLA-A 0201/NY-ESO-1157-165 redirected T-cells were generated, expanded and tested for CAR expression, cytokine release, in vitro cytolysis and protection against xenografted HLA-A 0201/NY-ESO-1157-165-positive multiple myeloma cells.
RESULTS:
A4 demonstrated antigen-specific binding to HLA-A 0201/NY-ESO-1157-165 redirected T-cells. Expansion with A4 resulted in 98% of HLA-A 0201/NY-ESO-1157-165 redirected T-cells. A4 induced strong proliferation, resulting in a 300-fold increase of redirected T-cells. After expansion protocols, redirected T-cells secreted Interleukin-2, (IL-2), interferon gamma (IFNγ) and tumor necrosis factor alpha (TNFα) and lysed target cells in vitro and were protective in vivo.
CONCLUSION:
A4 expanded HLA-A 0201/NY-ESO-1157-165 redirected T-cells with preservation of antigen-specific function.
AuthorsGopinadh Jakka, Petra C Schuberth, Markus Thiel, Gerhard Held, Frank Stenner, Maries Van Den Broek, Christoph Renner, Axel Mischo, Ulf Petrausch
JournalAnticancer research (Anticancer Res) Vol. 33 Issue 10 Pg. 4189-201 (Oct 2013) ISSN: 1791-7530 [Electronic] Greece
PMID24122982 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • CTAG1B protein, human
  • Immunoglobulin Fab Fragments
  • Membrane Proteins
Topics
  • Animals
  • Antibody Affinity
  • Antigens, Neoplasm (immunology)
  • CD8-Positive T-Lymphocytes (immunology, transplantation)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell-Free System
  • Coculture Techniques
  • Cytotoxicity, Immunologic
  • HEK293 Cells
  • Humans
  • Immunoglobulin Fab Fragments (immunology)
  • Immunotherapy, Adoptive
  • Lymphocyte Activation
  • Membrane Proteins (immunology)
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Multiple Myeloma (immunology, pathology, therapy)
  • Neoplasm Transplantation
  • T-Lymphocytes, Cytotoxic (immunology)
  • Tumor Burden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: